Clarifying binding difference of ATP and ADP to extracellular signal-regulated kinase 2 by using molecular dynamics simulations

被引:14
作者
Chen, Jianzhong [1 ]
机构
[1] Shandong Jiaotong Univ, Sch Sci, Jinan, Peoples R China
基金
中国国家自然科学基金;
关键词
extracellular signal-regulated kinase 2; MM-PBSA; molecular dynamics simulation; principal component analysis; FREE-ENERGY CALCULATION; PARTICLE MESH EWALD; PROTEIN-KINASE; COMPLEX-FORMATION; ADENYLATE KINASE; IN-VIVO; MM-PBSA; INHIBITORS; MECHANISM; RESISTANCE;
D O I
10.1111/cbdd.12877
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Extracellular signal-regulated kinase 2 is a promising target for designs and development of anticancer drugs. Molecular dynamics simulations and molecular mechanics Poisson-Boltzmann method were applied to study binding difference of ADP and ATP to extracellular signal-regulated kinase 2. The results prove that the binding ability of ATP to extracellular signal-regulated kinase 2 is stronger than that of ADP. Principal component analysis performed by using molecular dynamics trajectories suggests that binding of ADP and ATP to extracellular signal-regulated kinase 2 change motion directions of two helices a1 and alpha 2. Residue-based free energy decomposition method was adopted to calculate contributions of separate residues to associations of ADP and ATP with extracellular signal-regulated kinase 2. The results show that ADP and ATP produce strong CH-pi interactions with five residues Ile29, Val37, Ala50, Leu105, and Leu154. In addition, five hydrogen bonding interactions of ADP and ATP with residues Lys52, Gln103, Asp104, and Met106 also stabilize bindings of ADP and ATP to extracellular signal-regulated kinase 2. Overall, the CH-pi interactions of ATP with five residues Ile29, Val37, Ala50, Leu105, and Leu154 are stronger than ADP. This study is expected to contribute a significant theoretical hint for designs of anticancer drugs targeting extracellular signal-regulated kinase 2.
引用
收藏
页码:548 / 558
页数:11
相关论文
共 87 条
[1]   Accurate calculation of the absolute free energy of binding for drug molecules [J].
Aldeghi, Matteo ;
Heifetz, Alexander ;
Bodkin, Michael J. ;
Knappcd, Stefan ;
Biggin, Philip C. .
CHEMICAL SCIENCE, 2016, 7 (01) :207-218
[2]   Molecular dynamics simulation studies of GSK-3β ATP competitive inhibitors: understanding the factors contributing to selectivity [J].
Arfeen, Minhajul ;
Patel, Rahul ;
Khan, Tosif ;
Bharatam, Prasad V. .
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2015, 33 (12) :2578-2593
[3]   Ligand efficient tetrahydro-pyrazolopyridines as inhibitors of ERK2 kinase [J].
Bagdanoff, Jeffrey T. ;
Jain, Rama ;
Han, Wooseok ;
Poon, Daniel ;
Lee, Patrick S. ;
Bellamacina, Cornelia ;
Lindvall, Mika .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (17) :3626-3629
[4]  
Chaikuad A, 2014, NAT CHEM BIOL, V10, P853, DOI [10.1038/NCHEMBIO.1629, 10.1038/nchembio.1629]
[5]   Probing Origin of Binding Difference of inhibitors to MDM2 and MDMX by Polarizable Molecular Dynamics Simulation and QM/MM-GBSA Calculation [J].
Chen, Jianzhong ;
Wang, Jinan ;
Zhang, Qinggang ;
Chen, Kaixian ;
Zhu, Weiliang .
SCIENTIFIC REPORTS, 2015, 5
[6]   A comparative study of trypsin specificity based on QM/MM molecular dynamics simulation and QM/MM GBSA calculation [J].
Chen, Jianzhong ;
Wang, Jinan ;
Zhang, Qinggang ;
Chen, Kaixian ;
Zhu, Weiliang .
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2015, 33 (12) :2606-2618
[7]   A Comparative Insight into Amprenavir Resistance of Mutations V32I, G48V, I50V, I54V, and I84V in HIV-1 Protease Based on Thermodynamic Integration and MM-PBSA Methods [J].
Chen, Jianzhong ;
Wang, Xingyu ;
Zhu, Tong ;
Zhang, Qinggang ;
Zhang, John Z. H. .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2015, 55 (09) :1903-1913
[8]   A computational analysis of binding modes and conformation changes of MDM2 induced by p53 and inhibitor bindings [J].
Chen, Jianzhong ;
Wang, Jinan ;
Zhu, Weiliang ;
Li, Guohui .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2013, 27 (11) :965-974
[9]   AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with In vitro and In vivo Antitumor Activity [J].
Chresta, Christine M. ;
Davies, Barry R. ;
Hickson, Ian ;
Harding, Tom ;
Cosulich, Sabina ;
Critchlow, Susan E. ;
Vincent, John P. ;
Ellston, Rebecca ;
Jones, Darren ;
Sini, Patrizia ;
James, Dominic ;
Howard, Zoe ;
Dudley, Phillippa ;
Hughes, Gareth ;
Smith, Lisa ;
Maguire, Sharon ;
Hummersone, Marc ;
Malagu, Karine ;
Menear, Keith ;
Jenkins, Richard ;
Jacobsen, Matt ;
Smith, Graeme C. M. ;
Guichard, Sylvie ;
Pass, Martin .
CANCER RESEARCH, 2010, 70 (01) :288-298
[10]   Protein kinases - the major drug targets of the twenty-first century? [J].
Cohen, P .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (04) :309-315